Dexmedetomidine for the management of awake fibreoptic intubation

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 1, 2014, Pages

  He, Xing Ying ^a   Cao, Jian Ping ^b   He, Qian ^c   Shi, Xue Yin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The 455 Hospital of PLA   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; MIDAZOLAM; PLACEBO; PROPOFOL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT;

ADVERSE EVENT; AIRWAY OBSTRUCTION; AWAKE FIBEROPTIC INTUBATION; BRADYCARDIA; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPOTENSION; HYPOXIA; NASOTRACHEAL INTUBATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; ENDOTRACHEAL INTUBATION; META ANALYSIS; METHODOLOGY; WAKEFULNESS;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANTI-ANXIETY AGENTS; DEXMEDETOMIDINE; FENTANYL; HUMANS; HYPNOTICS AND SEDATIVES; INTUBATION, INTRATRACHEAL; MIDAZOLAM; PROPOFOL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WAKEFULNESS;

EID: 84903787742     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009798.pub2     Document Type: Review

References (32)

1. Bergese SD, Patrick Bender S, McSweeney TD, Fernandez S, Dzwonczyk R, Sage K. A comparative study of dexmedetomidine with midazolam and midazolam alone for sedation during elective awake fiberoptic intubation. Journal of Clinical Anesthsia 2010;22(1):35-40. [MEDLINE: 20206849]
2. Bergese SD, Candiotti KA, Bokesch PM, Zura A, Wisemandle W, Bekker AY. A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. American Journal of Therapeutics 2010;17(6):586-95. [MEDLINE: 20535016]
3. Chu KS, Wang FY, Hsu HT, Lu IC, Wang HM, Tsai CJ. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology 2010;27(1):36-40. [MEDLINE: 19550337]
4. Tsai CJ, Chu KS, Chen TI, Lu DV, Wang HM, Lu IC. A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia 2010;65(3):254-9. [MEDLINE: 20105150]
5. Boyd BC, Sutter SJ. Dexmedetomidine sedation for awake fiberoptic intubation of patients with difficult airways due to severe odontogenic cervicofacial infections. Journal of Oral and Maxillofacial Surgery 2011;69:1608-12. [MEDLINE: 21392875]
6. Swaniker J, Glick D. The impact of adjunct dexmedetomidine use on opioid requirements and hemodynamic stability during awake fiberoptic intubation. 2011 Annual Meeting of the International Anesthesia Research Society, IARS 2011, Vancouver, BC, Canada. [: conference proceedings]
7. Cattano D, Lam NC, Ferrario L, Seitan C, Vahdat K, Wilcox DW, et al. Dexmedetomidine versus remifentanil for sedation during awake fiberoptic intubation. Anesthesiology Research and Practice [electronic resource] 2012;Epub Jul 16. [MEDLINE: 22844277]
8. Hu R, Liu JX, Jiang H. Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation:a double-blinded randomized controlled trial. Journal of Anesthesia 2013;27:211-7. [MEDLINE: 23073729]
9. Li XB, Liu HQ, Meng XY, Yuan T, Han W, Tong T, et al. Application of dexmedetomidine combined with fibreoptic bronchoscope for tracheal intubation in difficult airways caused by huge goiter. Journal of Jilin Universtiy (Medical Edition) 2012;38:328-32.
10. Qiu L, Zhang L, Ji J. Sedation effect of dexmedetomidine on awake intubation in patients with difficult airway. Pharmaceutical Care and Research 2013;13:208-12.
11. Abdelmalak B, Makary L, Hoban J, Doyle DJ. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. Journal of Clinical Anesthesia 2007;19:370-3. [MEDLINE: 17869990]
12. Bailey PL, Pace NL, Ashburn MA, Moll JW, East KA, Stanley TH. Frequent hypoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990;73:826-30. [MEDLINE: 2122773]
13. Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. Journal of Clinical Anesthesia 2007;19:141-4. [MEDLINE: 17379129]
14. Coursin DB, Coursin DB, Maccioli GA. Dexmedetomidine. Current Opinion in Critical Care 2001;7:221-6. [MEDLINE: 11571417]
15. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;93:382-94. [MEDLINE: 10910487]
16. Gerlach AT, Dasta JF. Dexmedetomidine:an updated review. The Annals of Pharmacotherapy 2007;41:245-54. [MEDLINE: 17299013]
17. Grant SA, Breslin DS, MacLeod DB, Gleason D, Martin G. Dexmedetomidine infusion for sedation during fiberoptic intubation:a report of three cases. Journal of Clinical Anesthesia 2004;16:124-6. [MEDLINE: 15110375]
18. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesthesia and Analgesia 2000;90:699-705. [MEDLINE: 10702460]
19. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
20. Jooste EH, Ohkawa S, Sun LS. Fiberoptic intubation with dexmedetomidine in two children with spinal cord impingements. Anesthesia and Analgesia 2005;101:1248. [MEDLINE: 16192567]
21. Juni P, Altman D, Egger M. Systematic reviews in health care:assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6. [MEDLINE: 11440947]
22. Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology 2000;93:1345-9. [PUBMED: 11046225]
23. Knolle E, Oehmke MJ, Gustorff B, Hellwagner K, Kress HG. Target-controlled infusion of propofol for fibreoptic intubation. European Journal of Anaesthesiology 2003;20:565-9. [MEDLINE: 12884991]
24. Lallo A, Billard V, Bourgain JL. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesthesia and Analgesia 2009;108:852-7. [MEDLINE: 19224793]
25. Machata AM, Gonano C, Holzer A, Andel D, Spiss CK, Zimpfer M, et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and haemodynamic stability during conscious sedation with remifentanil. Anesthesia and Analgesia 2003;97:904-8. [MEDLINE: 12933427]
26. Maroof M, Khan RM, Jain D, Ashraf M. Dexmedetomidine is a useful adjunct for awake intubation. Canadian Journal of Anaesthesia 2005;52:776-7. [MEDLINE: 16103401]
27. Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. British Journal of Anaesthesia 2008;100:125-30. [MEDLINE: 18037667]
28. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
29. Rucher G, Schwarzer G, Garpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Statistics in Medicine 2008;27(5):746-63. [MEDLINE: 17592831]
30. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Criticical Care 2000;4:302-8. [MEDLINE: 11056756]
31. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. European Journal of Pharmacology 1988;150:9-14. [MEDLINE: 2900154]
32. He X, Shi X, He Q. Dexmedetomidine for the management of fibreoptic intubation. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD009798]